Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Millett

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|March 14, 2024
EU regulations for maximum containment labs-ResponsePiers Millett
Biologist (London, England)|December 10, 2002
Bioterrorism talkPiers Millett
Science (New York, N.Y.)|October 19, 2023
Safeguard the world's worst pathogensPiers Millett
Health Security|August 21, 2020
COVID-19, SARS-CoV-2, and Export ControlsPiers Millett, Paul Rutten
Engineering Biology|March 27, 2023
Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programmePiers Millett, Tessa Alexanian
Health Security|July 27, 2017
Human Agency and Global Catastrophic BiorisksPiers Millett, Andrew Snyder-Beattie
Health Security|August 15, 2017
Existential Risk and Cost-Effective BiosecurityPiers Millett, Andrew Snyder-Beattie
Health Security|February 17, 2022
The Dual-Use Education Gap: Awareness and Education of Life Science Researchers on Nonpathogen-Related Dual-Use ResearchSvenja Vinke, Irina Rais, Piers Millett
Medicine, Conflict, and Survival|June 5, 2002
The potential for abuse of genetics in militarily significant biological weaponsSimon Whitby, Piers Millett, Malcolm Dando
Antiviral Research|September 28, 2018
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development effortsMassinissa Si Mehand, Farah Al-Shorbaji, Piers Millett, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|March 14, 2024
EU regulations for maximum containment labs-ResponsePiers Millett
Biologist (London, England)|December 10, 2002
Bioterrorism talkPiers Millett
Science (New York, N.Y.)|October 19, 2023
Safeguard the world's worst pathogensPiers Millett
Health Security|August 21, 2020
COVID-19, SARS-CoV-2, and Export ControlsPiers Millett, Paul Rutten
Engineering Biology|March 27, 2023
Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programmePiers Millett, Tessa Alexanian
Health Security|July 27, 2017
Human Agency and Global Catastrophic BiorisksPiers Millett, Andrew Snyder-Beattie
Health Security|August 15, 2017
Existential Risk and Cost-Effective BiosecurityPiers Millett, Andrew Snyder-Beattie
Health Security|February 17, 2022
The Dual-Use Education Gap: Awareness and Education of Life Science Researchers on Nonpathogen-Related Dual-Use ResearchSvenja Vinke, Irina Rais, Piers Millett
Medicine, Conflict, and Survival|June 5, 2002
The potential for abuse of genetics in militarily significant biological weaponsSimon Whitby, Piers Millett, Malcolm Dando
Antiviral Research|September 28, 2018
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development effortsMassinissa Si Mehand, Farah Al-Shorbaji, Piers Millett, et al.
Pageof 2